Israel-based ForSight Robotics has completed a Series B funding round, raising $125m to fuel the growth phase of the robotic surgery platform intended for cataract and other eye conditions. Claimed to ...
If you or someone you love has had cataract surgery, you know how routine the whole thing can feel. You arrive, the surgeon does the procedure, and you are usually back home the same day. Now a robot ...
YOKNEAM ILLIT, Israel--(BUSINESS WIRE)--ForSight Robotics, the pioneer in ophthalmic robotic surgery, announced today it completed a $125M Series B round, led by Eclipse. The investment accelerates ...
Forbes says that more than 4 million cataract surgeries are performed each year in the U.S. alone. Yet, according to a World Health Organization report, over 1 billion people globally suffer from ...
ForSight Robotics, a pioneer in ophthalmic robotic surgery, announced it completed a $125 million Series B round led by Eclipse. Along with Eclipse, the funding round included significant ...
Please provide your email address to receive an email when new articles are posted on . All procedures were completed without manual intervention. Eleven of 14 patients underwent the procedure with ...
ForSight Robotics, a global pioneer in robotic eye surgery, today announced a significant milestone in the clinical evolution of ophthalmic robotics, demonstrating that fully robotic-assisted cataract ...
The company said more than two dozen ophthalmic surgeons have completed hundreds of procedures in animal models using the Oryom system. (ForSight Robotics) ForSight Robotics may be seeing stars after ...
ForSight Robotics, a company developing a robot to assist with ophthalmic surgery, announced it secured $125 million in a Series B funding round led by Eclipse, bringing the company's total raise to ...
The team at Israel-based ForSight Robotics has doubled in size over the past year, to more than 110 employees. · MedTech Dive · Courtesy of ForSight Robotics The above button links to Coinbase. Yahoo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results